Abstract:A series of novel 1-phenyl-5-amine-4-pyrazole thioether derivatives containing a 1,3,4-oxadiazole moiety was designed and synthesised. In vivo antiviral bioassay results showed that most of the target compounds exhibited excellent inactivation activity against Tobacco mosaic virus (TMV). The EC50 values of the inactivation activities for T2, T7, T9, T24, T25 and T27 were 15.7, 15.7, 15.5, 11.9, 12.5 and 16.5 μg/mL, respectively, which were remarkably superior over that of the commercialised antiviral agent ningnanmycin (40.3 μg/mL). Morphological study using AFM and TEM of TMV treated with T24 showed that T24 could significantly shorten the polymerization length of TMV particles and formed a distinct break on the rod-shaped TMV. Investigations for virus infection efficiency on tobacco leaves demonstrated that infectivity of virion had been reduced obviously upon T24 treatment. Subsequently, a strong interaction between T24 and TMV-CP (Kd = 3.8 μM, score 6.11) was observed through MST experiments. Molecular docking study further revealed that target compounds interact with amino acid residue Glu50 in TMV CP, causing disassembly of virion, shorting the length of the virion and reducing the infectivity of virion, and resulting in high inactivating activity of target compounds. This study provides a new insight for discovery of antiviral compounds through a new action mechanism with a new binding site.

Synthesis, Antiviral Activity, and Molecular Docking Study of Trans-Ferulic Acid Derivatives Containing Acylhydrazone Moiety.

Design, Synthesis, Bioactivity and Mechanism of Dithioacetal Derivatives Containing Dioxyether Moiety

Synthesis And Antiviral Activity Of Novel Myricetin Derivatives Containing Ferulic Acid Amide Scaffolds

Design, Synthesis, and Antiviral Activities of Coumarin Derivatives Containing Dithioacetal Structures

The Discovery of Novel Ferulic Acid Derivatives Incorporating Substituted Isopropanolamine Moieties as Potential Tobacco Mosaic Virus Helicase Inhibitors

Ferulic Acid Dimers as Potential Antiviral Agents by Inhibiting TMV Self-Assembly

Design, Synthesis, Anti-Tmv Activity, and Preliminary Mechanism of Cinnamic Acid Derivatives Containing Dithioacetal Moiety

Design, Synthesis, and Mechanism of Antiviral Acylurea Derivatives Containing a Trifluoromethylpyridine Moiety.

Synthesis and Antiviral Activity of Hydrogenated Ferulic Acid Derivatives

Antiviral Activity and Interaction Mechanisms Study of Novel Glucopyranoside Derivatives

Synthesis and bioactivity evaluation of penta-1,4-diene-3-one oxime ether derivatives

Design, Synthesis and Biological Evaluation of Novel N‐(4‐([2,2′:5′,2′′‐Terthiophen]‐5‐yl)‐2‐methylbut‐3‐yn‐2‐yl) Benzamide Derivatives

New Chalcone Derivatives: Synthesis, Antiviral Activity and Mechanism of Action

Design, Synthesis, Antiviral Bioactivity and Three-Dimensional Quantitative Structure-Activity Relationship Study of Novel Ferulic Acid Ester Derivatives Containing Quinazoline Moiety

Design, Synthesis, and Antiviral and Fungicidal Activities of 4-Oxo-4h-quinolin-1-yl Acylhydrazone Derivatives

Discovery and SARs of trans-3-aryl acrylic acids and their analogs as novel anti-tobacco mosaic virus (TMV) agents.

Discovery of Novel Indole Derivatives Containing Dithioacetal As Potential Antiviral Agents for Plants

Pyrazolo[3,4-d]pyrimidine Derivatives Containing a Schiff Base Moiety As Potential Antiviral Agents

Discovery of Dithioacetal Derivatives Containing Sulfonamide Moiety of Novel Antiviral Agents by TMV Coat Protein As a Potential Target

Novel Α,β-Unsaturated Amide Derivatives Bearing Α-Amino Phosphonate Moiety As Potential Antiviral Agents

In vivo antiviral activity and disassembly mechanism of novel 1-phenyl-5-amine-4-pyrazole thioether derivatives against Tobacco mosaic virus